[
    [
        {
            "time": "",
            "original_text": "智飞生物重磅品种就要批了 新政之下还有哪些重磅新药将获批？",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重磅品种",
                    "新政",
                    "新药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物重磅品种就要批了 新政之下还有哪些重磅新药将获批？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "招商证券：三大方面深度解析血制品行业(个股分析)",
            "features": {
                "keywords": [
                    "招商证券",
                    "血制品",
                    "行业分析",
                    "个股分析"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "血制品"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "招商证券：三大方面深度解析血制品行业(个股分析)",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【东北医药崔洁铭/马千里】天坛生物（600161）年报点评：公司业绩稳健增长，血液制品需求旺盛",
            "features": {
                "keywords": [
                    "天坛生物",
                    "年报点评",
                    "业绩增长",
                    "血液制品",
                    "需求旺盛"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "血液制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【东北医药崔洁铭/马千里】天坛生物（600161）年报点评：公司业绩稳健增长，血液制品需求旺盛",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]